SOCS3 is an endogenous inhibitor of pathologic angiogenesis. - Wikidata - thesis-toulmin - TriplyDB

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

http://www.wikidata.org/entity/Q36305360

about

Novel endogenous angiogenesis inhibitors and their therapeutic potential SOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines The future of EPAC-targeted therapies: agonism versus antagonism IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes.Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy.Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.Endothelial TWIST1 promotes pathological ocular angiogenesis.Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.SOCS3 in retinal neurons and glial cells suppresses VEGF signaling to prevent pathological neovascular growth IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis.Effects of Controlled Cortical Impact on the Mouse Brain Vasculome.CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy.IDO1 is an Integral Mediator of Inflammatory Neovascularization.STAT3 inhibitors: finding a home in lymphoma and leukemia.Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing.Induction of SOCS3 by liver X receptor suppresses the proliferation of hepatocellular carcinoma cells SOCS3-mediated blockade reveals major contribution of JAK2/STAT5 signaling pathway to lactation and proliferation of dairy cow mammary epithelial cells in vitro.Dysregulation of Calpain Proteolytic Systems Underlies Degenerative Vascular Disorders.Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney.The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization.Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'.Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3.Enhanced SOCS3 in osteoarthiritis may limit both proliferation and inflammation.

P2860

Q26781297-99781B00-3CA3-4B65-9AD4-5678508A868B Q26853718-31B157FB-3794-4D58-8461-F66AEC948B9F Q34465923-BF243AC9-5FC7-42ED-874D-EA75952D0075 Q35048439-A129AAE4-66D0-410D-A9AE-D0B26A1BBD93 Q35085010-15B5DDDD-634D-4FB0-AB70-A1B28BDDD0D7 Q35239541-2B0AA4B4-8E98-4A6A-81B2-112A05C76E0D Q35441276-E1351810-4F3D-4C8B-8E8A-87073BB9F09E Q35989713-E4BBCDA1-5C0C-492B-83F1-E75F7ADA57B0 Q36318857-F6FA17A6-E4F3-4BDC-8663-5B25E0987D64 Q37031844-404FD494-A1CB-4223-AB59-DEB0638C76B3 Q37062141-04639BA5-F0EF-477D-BA50-E808F6A115D7 Q37179640-C0AE876D-C58B-48F3-BF5F-0DB432D41323 Q37510171-E949314B-1CB9-450D-9BC0-4158C171DC24 Q38202556-60E97213-C30B-447E-BECA-0453A13D0988 Q39220891-205BD35E-E45C-4DF6-9FD1-A5444D21F18F Q41158794-AD9A0510-D2E4-4AF9-B677-F6772B34BD54 Q41888020-4B266DF5-10D9-4167-BAE5-A7DB88E16A10 Q44954641-CBB33E92-BA6C-46DC-83FA-08F924A2A079 Q47937998-D8BE91A7-18EE-42D6-8CE2-1F075B7C4CB6 Q47956039-45159571-F746-40D7-BF35-7FC9D44E7471 Q48172039-68FC3111-3581-4653-A77F-C9859F434D45 Q49991844-6F48B6A4-59CC-4F54-9746-53DAEC804372 Q50136955-F80C67F1-81CF-4AB1-8D79-F10410A64A36 Q50138585-95B27B4F-B481-486A-AF4A-F76E7035FC63 Q51052506-6BADA21F-704F-4CA8-887C-D5AD6B21CB2B Q51098308-B5B3B2E3-8B76-4B19-B29C-4FE1C06A17E8

P2860

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

http://www.wikidata.org/entity/Q36305360

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

@ast

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

@en

type

label

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

@ast

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

@en

prefLabel

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

@ast

SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

@en

P1433

Q36305360-D9CE34D1-074A-4B2B-93F1-67D4DDA4B10E

P1476

Q36305360-945E5B3E-4E1E-48E3-9AC9-A5632A249D05

P2093

Q36305360-040777C6-9A8F-4EB8-B58C-594E112578B7

Q36305360-33BAC349-A3DE-4B4D-975B-743F98681CCA

Q36305360-42E5DA9B-6E88-4061-9E00-534CA622AEA1

Q36305360-482416BA-ADB3-4702-95B8-52582481E4E1

Q36305360-571DC246-D83E-4DAB-A7F9-49F77BDAD6A5

Q36305360-5F83511B-F13C-428C-8C20-08521A40735D

Q36305360-7764D1B6-FF82-4A2C-8270-62C2F4CF6CF0

Q36305360-7979E1B8-9DF4-4A6B-B72F-64FEF7928483

Q36305360-8AC18C52-DC45-40E8-870B-EC0B26612CF1

Q36305360-A5F2D61A-5D60-446A-8045-6658DDBC7462

P2860

Q36305360-0150AFA5-43EF-4D8B-A419-7D84A55A49EC

Q36305360-08DB43C0-F3C5-427D-A5F7-A79072E38D7A

Q36305360-254E8C4B-01E0-4761-ACBF-30A7C6F414BF

Q36305360-25DEBE44-BE9C-45C7-9F12-BFC517E8204C

Q36305360-2C0B5778-A8A1-4F42-B074-7FF24F919012

Q36305360-3BFE1914-1D97-46E4-8657-B040BC4A4630

Q36305360-3F154C06-B637-42E6-8968-FA793455DEFC

Q36305360-489636DD-A260-40EE-A3A6-00F21090541D

Q36305360-4CA07832-4A9D-4EAB-B53A-EE237FE1D09F

Q36305360-52C406BA-9F07-4D26-B23B-D1090D8CDF74

P304

Q36305360-5C6E7B4B-4873-4603-B005-AF3C81A295F1

P31

Q36305360-4119EAB5-F49F-492A-83D4-064D5001623F

P356

Q36305360-4737B1A1-4052-4922-B352-1AB74576A8DC

P407

Q36305360-90C1481C-348E-487F-A11F-6CB7786408D5

P433

Q36305360-0ACDE630-FCBA-465E-85C9-D40CA4292076

P478

Q36305360-FE6A9055-0E2A-49FD-BC13-F535F5D0BA35

P50

Q36305360-F7D1602F-A7B4-4827-AEA2-EAAF418ED55B

Q36305360-F92246D5-7F30-47B9-A08B-6866E9D9812C

P577

Q36305360-06A6526E-1C9F-4F85-B71F-53B78183B4EF

P5875

Q36305360-33233A0C-F47A-461D-A5CE-CBFF92E1F8E0

P698

Q36305360-D13C538A-1A8A-428D-A340-B5A4391A968A

P932

Q36305360-85354B04-5973-4E7D-8D28-5804AC976642

P356

BLOOD-2012-04-422527

P1433

P1476

SOCS3 is an endogenous inhibitor of pathologic angiogenesis

@en

P2093

Andreas Stahl

http://www.w3.org/2001/XMLSchema#string

Christian G Hurst

http://www.w3.org/2001/XMLSchema#string

Colman J Hatton

http://www.w3.org/2001/XMLSchema#string

Dipak Panigrahy

http://www.w3.org/2001/XMLSchema#string

Dorothy T Pei

http://www.w3.org/2001/XMLSchema#string

Emily R Greene

http://www.w3.org/2001/XMLSchema#string

Jean-Sebastian Joyal

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Lois E H Smith

http://www.w3.org/2001/XMLSchema#string

Molly R Seaward

http://www.w3.org/2001/XMLSchema#string

P2860

A family of cytokine-inducible inhibitors of signalling

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3

Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.

Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor

SOCS3 is essential in the regulation of fetal liver erythropoiesis

Cytokine signaling in the brain: putting a SOCS in it?

A global double-fluorescent Cre reporter mouse

The mouse retina as an angiogenesis model.

Computer-aided quantification of retinal neovascularization.

P304

2925-2929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-04-422527

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229082307

http://www.w3.org/2001/XMLSchema#string

P698

22791286

http://www.w3.org/2001/XMLSchema#string

P932

3466973

http://www.w3.org/2001/XMLSchema#string